sarcoma section

Sarcoma News & Features

Indications for pazopanib

Indications for pazopanib

Is pazopanib (Votrient) approved for the treatment of leiomyosarcoma?

Resistant sarcomas slowed by new therapeutic combination

A new therapeutic combination to combat resistant sarcomas has shown promise in a trial.

Hemipelvectomy: Providing evidence-based nursing care

Meeting the challenges of the significant morbidity, functional impairment, and alterations in body image in patients undergoing this surgical resection.

Doxorubicin-ifosfamide combo improves progression-free survival in soft-tissue sarcoma

A new European study does not support administration of intensified doxorubicin and ifosfamide for palliation of advanced soft tissue sarcoma.

Prognostic factors of pazopanib in advanced soft tissue sarcomas

A new analysis confirmed the importance of known prognostic factors such as performance status and tumor grading for having a long-term outcome in patients treated with pazopanib for metastatic soft tissue sarcoma. In addition, hemoglobin at baseline was found to be a new prognostic factor.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs